Patents by Inventor Filip Novak

Filip Novak has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Precursors of glutamate derivatives
    Patent number: 9000037
    Abstract: This invention relates to novel precursors suitable for 18F radiolabeling of glutamate derivatives, methods for preparing such compounds and its intermediates, compositions comprising such compounds, kits comprising such compounds or compositions and methods for 18F radiolabeling of glutamate derivatives wherein the obtained 18F radiolabeled glutamate derivatives are suitable for diagnostic imaging by Positron Emission Tomography (PET) of proliferative diseases e.g. tumor in mammals.
    Type: Grant
    Filed: April 30, 2012
    Date of Patent: April 7, 2015
    Assignee: Piramal Imaging SA
    Inventors: Christina Hultsch, Michael Harre, Filip Novak, Mathias Berndt, Matthias Friebe, Heribert Schmitt-Willich, Dae Yoon Chi, Byoung Se Lee, Sang Don Park
  • NOVEL PRECURSORS OF GLUTAMATE DERIVATIVES
    Publication number: 20140243532
    Abstract: This invention relates to novel precursors suitable for 18F radiolabeling of glutamate derivatives, methods for preparing such compounds and its intermediates, compositions comprising such compounds, kits comprising such compounds or compositions and methods for 18F radiolabeling of glutamate derivatives wherein the obtained 18F radiolabeled glutamate derivatives are suitable for diagnostic imaging by Positron Emission Tomography (PET) of proliferative diseases e.g. tumor in mammals.
    Type: Application
    Filed: April 30, 2012
    Publication date: August 28, 2014
    Applicant: PIRAMAL IMAGING SA
    Inventors: Christina Hultsch, Michael Harre, Filip Novak, Mathias Berndt, Matthias Friebe, Heribert Schmitt-Willich, Dae Yoon Chi, Byoung Se Lee, Sang Don Park
  • PARTICLES COMPRISING DROSPIRENONE ENCAPSULATED IN A POLYMER
    Publication number: 20120114757
    Abstract: The present invention relates to particles comprising Drospirenone encapsulated in a polymer selected from the group consisting of glycolic acid polymer, lactic acid polymer, poly caprolactones, poly anhydrides and any copolymer of these, e.g., poly(lactic acid-co-glycolic acid) polymer and any combination of these. Furthermore, the present invention also relates to compositions comprising such particles. The present invention also relates to the use of such particles or compositions as contraceptives and for treatment of diseases, disorders and symptoms associated with deficient endogenous levels of estrogen in women.
    Type: Application
    Filed: February 12, 2010
    Publication date: May 10, 2012
    Applicant: BAYER PHARMA AKTIENGESELLSCHAFT
    Inventors: Sascha General, Filip Novak